Objective surveillance definitions for ventilator-associated pneumonia
- PMID: 22990454
- DOI: 10.1097/CCM.0b013e318260c6d9
Objective surveillance definitions for ventilator-associated pneumonia
Abstract
Objectives: The subjectivity and complexity of surveillance definitions for ventilator-associated pneumonia preclude meaningful internal or external benchmarking and therefore hamper quality improvement initiatives for ventilated patients. We explored the feasibility of creating objective surveillance definitions for ventilator-associated pneumonia.
Design: We identified clinical signs suitable for inclusion in objective definitions, proposed candidate definitions incorporating these objective signs, and then applied these definitions to retrospective clinical data to measure their frequencies and associations with adverse outcomes using multivariate regression models for cases and matched controls.
Setting: Medical and surgical intensive care units in eight U.S. hospitals (four tertiary centers, three community hospitals, and one Veterans Affairs institution).
Patients: Eight thousand seven hundred thirty-five consecutive episodes of mechanical ventilation for adult patients.
Interventions: We evaluated 32 different candidate definitions composed of different combinations of the following signs: three thresholds for respiratory deterioration defined by sustained increases in daily minimum positive end-expiratory pressure or FIO2 after either 2 or 3 days of stable or decreasing ventilator settings, abnormal temperature, abnormal white blood cell count, purulent pulmonary secretions defined by neutrophils on Gram stain, and positive cultures for pathogenic organisms.
Measurements and main results: Ventilator-associated pneumonia incidence, attributable ventilator days, hospital days, and hospital mortality. All candidate definitions were significantly associated with increased ventilator days and hospital days, but only definitions requiring objective evidence of respiratory deterioration were significantly associated with increased hospital mortality. Significant odds ratios for hospital mortality ranged from 1.9 (95% confidence interval 1.2-2.9) to 6.1 (95% confidence interval 2.2-17). Requiring additional clinical signs beyond respiratory deterioration alone decreased event rates, had little impact on attributable lengths of stay, and diminished sensitivity and positive predictive values for hospital mortality.
Conclusions: Objective surveillance definitions that include quantitative evidence of respiratory deterioration after a period of stability strongly predict increased length of stay and hospital mortality. These definitions merit further evaluation of their utility for hospital quality and safety improvement programs.
Comment in
-
Diagnosis of ventilator-associated pneumonia: do we need surrogate parameters?Crit Care Med. 2012 Dec;40(12):3311-2. doi: 10.1097/CCM.0b013e31826566a1. Crit Care Med. 2012. PMID: 23164773 No abstract available.
Similar articles
-
The Centers for Disease Control and Prevention's New Definitions for Complications of Mechanical Ventilation Shift the Focus of Quality Surveillance and Predict Clinical Outcomes in a PICU.Crit Care Med. 2015 Nov;43(11):2446-51. doi: 10.1097/CCM.0000000000001261. Crit Care Med. 2015. PMID: 26468698
-
Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.Crit Care Med. 2003 May;31(5):1312-7. doi: 10.1097/01.CCM.0000063087.93157.06. Crit Care Med. 2003. PMID: 12771596
-
Ventilator-associated events surveillance: a patient safety opportunity.Curr Opin Crit Care. 2013 Oct;19(5):424-31. doi: 10.1097/MCC.0b013e3283636bc9. Curr Opin Crit Care. 2013. PMID: 23778075 Review.
-
Continuous lateral rotation therapy to prevent ventilator-associated pneumonia.Crit Care Med. 2010 Feb;38(2):486-90. doi: 10.1097/CCM.0b013e3181bc8218. Crit Care Med. 2010. PMID: 19789440 Clinical Trial.
-
Ventilator-associated pneumonia in neonatal and pediatric intensive care unit patients.Clin Microbiol Rev. 2007 Jul;20(3):409-25, table of contents. doi: 10.1128/CMR.00041-06. Clin Microbiol Rev. 2007. PMID: 17630332 Free PMC article. Review.
Cited by
-
Do endotracheal tubes with suction above the cuff decrease the rate of ventilator-associated pneumonia, and are they cost-effective?Rev Bras Ter Intensiva. 2012 Dec;24(4):320-1. doi: 10.1590/s0103-507x2012000400004. Rev Bras Ter Intensiva. 2012. PMID: 23917926 Free PMC article. No abstract available.
-
The effect of ventilator-associated pneumonia on the prognosis of intensive care unit patients within 90 days and 180 days.BMC Infect Dis. 2021 Jul 15;21(1):684. doi: 10.1186/s12879-021-06383-2. BMC Infect Dis. 2021. PMID: 34266399 Free PMC article.
-
Systematic review of studies investigating ventilator associated pneumonia diagnostics in intensive care.BMC Pulm Med. 2021 Jun 9;21(1):196. doi: 10.1186/s12890-021-01560-0. BMC Pulm Med. 2021. PMID: 34107929 Free PMC article.
-
Costs associated with health care-associated infections in cardiac surgery.J Am Coll Cardiol. 2015 Jan 6;65(1):15-23. doi: 10.1016/j.jacc.2014.09.079. J Am Coll Cardiol. 2015. PMID: 25572505 Free PMC article.
-
The preventability of ventilator-associated events. The CDC Prevention Epicenters Wake Up and Breathe Collaborative.Am J Respir Crit Care Med. 2015 Feb 1;191(3):292-301. doi: 10.1164/rccm.201407-1394OC. Am J Respir Crit Care Med. 2015. PMID: 25369558 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources